Zahraa Talib Khudhair, Shihab MS, Hamah-Ameen B. Drugs that Might Be Possibly Used for Treatment of COVID-19 Patients.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2021;
47:789-804. [PMID:
34456540 PMCID:
PMC8380022 DOI:
10.1134/s1068162021040130]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Revised: 10/26/2020] [Accepted: 10/31/2020] [Indexed: 11/23/2022]
Abstract
The drug development process for Coronavirus disease (COVID-19) is the research process to create a preventive vaccine or therapeutic prescription drug to relieve the severity of 2019-2020 (COVID-19). In different stages of preclinical or clinical research, several hundred special scientific research centers, research organizations, and health agencies have developed and tried enormous numbers of vaccine candidates and new drugs for COVID-19 disease. In order to identify new therapies against COVID-19, several clinical trials have been in progress worldwide.
Collapse